MK0653, ezetimibe + Comparator: placebo

Phase 3Completed

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Lipid Metabolism, Inborn Errors

Conditions

Lipid Metabolism, Inborn Errors, Heart Disease

Trial Timeline

Feb 12, 2001 → Nov 30, 2004

NCT ID

NCT00092807

About MK0653, ezetimibe + Comparator: placebo

MK0653, ezetimibe + Comparator: placebo is a phase 3 stage product being developed by Organon for Lipid Metabolism, Inborn Errors. The current trial status is completed. This product is registered under clinical trial identifier NCT00092807. Target conditions include Lipid Metabolism, Inborn Errors, Heart Disease.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (3)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00092898	Phase 3	Completed	Oct 1, 2004	Oct 1, 2005	Lipid Metabolism, Inborn Errors
NCT00092807	Phase 3	Completed	Feb 12, 2001	Nov 30, 2004	Lipid Metabolism, Inborn Errors
NCT00092820	Phase 3	Completed	Feb 12, 2001	Nov 30, 2004	Lipid Metabolism, Inborn Errors

Competing Products

20 competing products in Lipid Metabolism, Inborn Errors

See all competitors

Product	Company	Stage	Hype Score
VK2809 + Placebo	Viking Therapeutics	Phase 2	47
LY3202328 + Placebo + Atorvastatin + Simvastatin	Eli Lilly	Phase 1	33
Pitavastatin + Pravastatin	Eli Lilly	Approved	85
RAY121	Chugai Pharmaceutical	Phase 1	33
RAY121	Chugai Pharmaceutical	Phase 1	33
Rosuampin 10/5mg + Rosuampin 20/5mg + Amlodipine/Atorvastatin 5/20mg	Yuhan	Approved	85
YH14755 + Metformin + Rosuvastatin	Yuhan	Phase 3	77
YHR1705 + YHR1706 + YHR1705+YHR1706	Yuhan	Phase 1	33
YHP1701 + YHR1703 + YHR1704	Yuhan	Phase 3	77
YH16410 + Rosuvastatin + Telmisartan + YH16410 placebo + Rosuvastatin placebo + Telmisartan placebo	Yuhan	Phase 3	77
Moderate-intensity statin monotherapy + Ezetimibe or ezetimibe-statin combination therapy	Yuhan	Pre-clinical	23
Crestor 20mg(Rosuvastatin 20mg), Micardis 80mg(Telmisartan 80mg) , FDC	Yuhan	Phase 1	33
Diet+pravastatin	Daiichi Sankyo	Approved	85
Mevalotin	Daiichi Sankyo	Pre-clinical	23
Pravastatin	Daiichi Sankyo	Pre-clinical	23
Bempedoic acid 180 mg tablet	Daiichi Sankyo	Approved	85
Minute Maid Heart Wise orange juice + Welchol	Daiichi Sankyo	Approved	85
Pravafen + Pravastatin + Fenofibrate	Shionogi	Phase 3	77
LY3475766 - IV + LY3475766 - SC + Placebo - IV + Placebo - SC	Eli Lilly	Phase 1	33
LY3885125 + Placebo	Eli Lilly	Phase 1	33

Other Products from Organon

desloratadineApproved

tibolone + raloxifenApproved

ezetimibe + statinsApproved

losartan potassium + Comparator: carvedilol + Comparator: losartan (+) hydrochlorothiazide (HCTZ) + Comparator: carvedilol (+) hydrochlorothiazideApproved

Desloratadine 5 mg + fexofenadineApproved